drugmaker scale back sharp hike price pregnancy drug
washington louis drug company lambasted increasing price pregnancy drug dose announced friday cutting price half
sharp reduction per dose came two day food drug administration publicly invited competition
drug synthetic form progesterone commonly called marketed trade name makena recommended woman high risk delivering prematurely
drug administered via injection weekly week
friday announcement pharmaceutical percent price reduction put list cost full course treatment
old price still sharp jump woman could expect spend drug made compounding pharmacy
year version available
alternative woman take prescription drug compounding pharmacy produced individual batch dose
february fda granted pharmaceutical exclusive right make makena seven year
subsequently priced dose sent letter warning compounding pharmacy fda crackdown stop making version
fda reacted wednesday saying planning blocking compounding pharmacy making drug essentially encouraging patient go route
defended pricing justified development cost
fda noted relied study national institute health demonstrate drug effectiveness
